GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for peptide methionine sulfoxide reductase msra (P0A744)

Analyse AlphaFold monomer V2.0 prediction for peptide methionine sulfoxide reductase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
P0A744
Type
protein
Length
212 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xBd1df4520bd720D8bA9c973740d544444e1D22F2
Molecule
Peptide methionine sulfoxide reductase msra
UniProt
P0A744

Structure

1 distinct chain · 25% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeptide methionine sulfoxide reductase msraprotein21225% helix, 17% strandP0A744

Compared structures

  • 1FF3 · Structure of the peptide methionine sulfoxide reductase from escherichia COLI · an experimental structure of the same protein · chain A against A, TM-score 0.97
  • 1FF3 · Structure of the peptide methionine sulfoxide reductase from escherichia COLI · an experimental structure of the same protein · chain A against A, TM-score 0.97
  • 6YEV · Crystal structure of MsrA C206 and Trx C35S complex from Escherichia coli · an experimental structure of the same protein · chain A against A, TM-score 0.96
  • 6YEV · Crystal structure of msra C206 and trx C35S complex from escherichia COLI · an experimental structure of the same protein · chain A against A, TM-score 0.96
  • 2GT3 · Solution structure and dynamics of the reduced form of Methionine Sulfoxide Reductase A… · an experimental structure of the same protein · chain A against A, TM-score 0.89
  • 2GT3 · Solution structure and dynamics of the reduced form of methionine sulfoxide reductase a… · an experimental structure of the same protein · chain A against A, TM-score 0.89

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.